Premium
Low‐dose Doxorubicin in the Management of Advanced Carcinoma of the Prostate
Author(s) -
ROBINSON M. R. G.,
CHANDRYSEKRAN S.,
NEWLING D. W. W.,
RICHARDS B.,
SMITH P. H.
Publication year - 1983
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1983.tb03418.x
Subject(s) - doxorubicin , prostate carcinoma , medicine , prostate , carcinoma , oncology , urology , chemotherapy , cancer
Summary— Twenty‐one patients with advanced metastatic carcinoma of the prostate, no longer responsive to conventional therapy, were treated with weekly low‐dose doxorubicin (Adriamycin). Twelve had an impressive subjective response in terms of pain relief and improved performance status and in nine this was maintained for 3 or more months.